Lipocine (LPCN.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov18

Lipocine Inc. Announces Positive Mid-Trial Safety Results for Postpartum Depression Drug LPCN 1154

13:03

Nov7

Lipocine released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 114.57 K (forecast USD 238 K), actual EPS USD -0.59 (forecast USD -0.54)

04:00

Lipocine released FY2025 9 Months Earnings on November 6 (EST), actual revenue USD 831.29K, actual EPS USD -1.3521

04:00

Aug6

Lipocine released FY2025 Q2 earnings on August 5 (EST), actual revenue USD 622.85 K (forecast USD 229 K), actual EPS USD -0.4121 (forecast USD -0.4)

03:00

Lipocine released FY2025 Semi-Annual earnings on August 5 (EST), actual revenue USD 716.71 K, actual EPS USD -0.7608

03:00

Jul9

Lipocine Hosts Virtual Event for Postpartum Depression Treatment

15:31

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 114.57 K, Net Income -3.187 M, EPS -0.59

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 622.85 K, Net Income -2.206 M, EPS -0.4121

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 93.86 K, Net Income -1.865 M, EPS -0.35

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change